|
US3687808A
(en)
|
1969-08-14 |
1972-08-29 |
Univ Leland Stanford Junior |
Synthetic polynucleotides
|
|
US5578493A
(en)
*
|
1993-09-01 |
1996-11-26 |
The Trustees Of Columbia University In The City Of New York |
Wilson's disease gene
|
|
CA2108927C
(en)
|
1993-09-21 |
2008-09-02 |
Peter Bull |
Wilson disease gene
|
|
TW520293B
(en)
|
1995-11-22 |
2003-02-11 |
Univ Johns Hopkins Med |
Delivery system to enhance cellular uptake of biomolecules
|
|
US20040101854A1
(en)
*
|
2002-11-21 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of BCL2-associated athanogene expression
|
|
US7491805B2
(en)
|
2001-05-18 |
2009-02-17 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
|
US20030180953A1
(en)
|
2000-12-29 |
2003-09-25 |
Elitra Pharmaceuticals, Inc. |
Gene disruption methodologies for drug target discovery
|
|
US20040126761A1
(en)
*
|
2002-12-10 |
2004-07-01 |
Isis Pharmaceuticals Inc. |
Modulation of alpha-methylacyl-CoA racemase expression
|
|
WO2004035819A2
(en)
|
2002-10-21 |
2004-04-29 |
Exiqon A/S |
Oligonucleotide analogues for detecting and analyzing nucleic acids
|
|
US20050244851A1
(en)
|
2004-01-13 |
2005-11-03 |
Affymetrix, Inc. |
Methods of analysis of alternative splicing in human
|
|
EP1718741A2
(en)
*
|
2004-01-29 |
2006-11-08 |
Cellzome Ag |
Treatment of neurodegenerative diseases by the use of atp7a
|
|
CA2566286A1
(en)
|
2004-05-11 |
2005-12-08 |
Rnai Co., Ltd. |
Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same
|
|
CA2566519C
(en)
|
2004-05-14 |
2020-04-21 |
Rosetta Genomics Ltd. |
Micrornas and uses thereof
|
|
US20070048756A1
(en)
|
2005-04-18 |
2007-03-01 |
Affymetrix, Inc. |
Methods for whole genome association studies
|
|
EP1783645A1
(en)
*
|
2005-11-08 |
2007-05-09 |
Actigenics |
Methods for the identification of microRNA and their applications in research and human health
|
|
US8178503B2
(en)
|
2006-03-03 |
2012-05-15 |
International Business Machines Corporation |
Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
|
|
JP4841279B2
(ja)
|
2006-03-23 |
2011-12-21 |
一般財団法人 化学物質評価研究機構 |
被検物質の発がん性予測方法
|
|
EP2229186A2
(en)
|
2007-12-04 |
2010-09-22 |
Alnylam Pharmaceuticals Inc. |
Carbohydrate conjugates as delivery agents for oligonucleotides
|
|
BR112014016870A2
(pt)
*
|
2012-01-09 |
2017-06-27 |
Huesken Dieter |
composições orgânicas para tratar doenças relacionadas com beta-catenina
|
|
WO2014036301A1
(en)
*
|
2012-08-30 |
2014-03-06 |
Isis Pharmaceuticals, Inc. |
Modulation of copper related diseases by ctr1
|
|
PL2992098T3
(pl)
|
2013-05-01 |
2019-09-30 |
Ionis Pharmaceuticals, Inc. |
Kompozycje i sposoby modulowania ekspresji hbv i ttr
|
|
US20160258005A1
(en)
*
|
2013-07-02 |
2016-09-08 |
The Trustees Of The University Of Pennsylvania |
Methods for rapid ribonucleic acid fluorescence in situ hybridization
|
|
CN106061981A
(zh)
|
2013-11-06 |
2016-10-26 |
索尔斯蒂斯生物有限公司 |
具有二硫化物基团的多核苷酸构建体
|
|
CN107109405A
(zh)
|
2014-06-06 |
2017-08-29 |
索尔斯蒂斯生物有限公司 |
具有生物可逆性和非生物可逆性基团的多核苷酸构建体
|
|
EP3164420A4
(en)
|
2014-06-30 |
2018-05-23 |
Tarveda Therapeutics, Inc. |
Targeted conjugates and particles and formulations thereof
|
|
AU2015346042A1
(en)
|
2014-11-14 |
2017-04-27 |
Ionis Pharmaceuticals, Inc. |
Compounds and methods for the modulation of proteins
|
|
US20180002379A1
(en)
|
2015-01-21 |
2018-01-04 |
Sangamo Therapeutics, Inc. |
Methods and compositions for identification of highly specific nucleases
|
|
CN105986015B
(zh)
*
|
2015-02-05 |
2020-10-23 |
大连晶泰生物技术有限公司 |
一种基于高通量测序的多样本的一个或多个靶序列的检测方法和试剂盒
|
|
EP3286318A2
(en)
|
2015-04-22 |
2018-02-28 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
EP3386517A4
(en)
|
2015-12-08 |
2019-08-07 |
Solstice Biologics, Ltd. |
POLYNUCLEOTIDE CONSTRUCTS COMPRISING AN AUXILIARY FRACTION RELATED NON-BIOREVERSIBLE TO AN INTERNETOSIDIC PHOSPHATE OR PHOSPHOROTHIOATE
|
|
US11096956B2
(en)
|
2015-12-14 |
2021-08-24 |
Stoke Therapeutics, Inc. |
Antisense oligomers and uses thereof
|
|
WO2017106283A1
(en)
*
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of liver diseases
|
|
KR101743211B1
(ko)
|
2016-06-24 |
2017-06-15 |
주식회사 녹십자지놈 |
선천성 기능장애 진단용 조성물 및 이의 용도
|
|
CA3107890A1
(en)
*
|
2018-08-21 |
2020-02-27 |
Deep Genomics Incorporated |
Therapeutic splice-switching oligonucleotides
|
|
IL308353A
(en)
*
|
2021-05-10 |
2024-01-01 |
Entrada Therapeutics Inc |
Compositions and methods for modulating tissue distribution of intracellular therapies
|
|
WO2022256283A2
(en)
*
|
2021-06-01 |
2022-12-08 |
Korro Bio, Inc. |
Methods for restoring protein function using adar
|